Page 79 | Certara

On-Demand Webinar

Higher Standards: Achieving Cleaner Data, Faster, from Protocol to Submission

Join our webinar to explore best practices for harnessing the power of standards, without a…

CertaraJanuary 16, 2024

Publication

Real-world application of PBPK in drug discovery

The utility of PBPK models in support of drug development has been well documented. During…

CertaraJanuary 11, 2024

On-Demand Webinar

Industrializing Quantitative Systems Pharmacology (QSP): Why now and how.

What does it take to industrialize QSP? What is the right mix of technology and…

CertaraJanuary 9, 2024

Fact Sheet

Moving from Molecule to Market

CertaraJanuary 5, 2024

Press Coverage

MedCity News | How the IRA Has Created a New Environment for Biosimilars

By Maximillian Vargas and Caitlin Verrilli As IRA provisions are activated, the law’s impact on…

CertaraJanuary 5, 2024

Press Coverage

Clinical Research News | Trendspotting: What’s Coming for Clinical Trials and Research in 2024

By Clinical Research Team We spoke with leaders and experts in the Clinical Research community…

CertaraJanuary 5, 2024

Press Coverage

Bio-IT World | Trendspotting: What’s Coming for Biotech in 2024

By Bio-IT World Team To kick off the New Year, we spoke with leaders and…

CertaraJanuary 5, 2024

Publication

Physiologically Based Pharmacokinetic modelling of drugs in pregnancy: A mini-review on availability and limitations

This mini-review provides a concise and comprehensive overview of the pregnancy PBPK field and identify…

CertaraJanuary 3, 2024

Publication

A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy

This comprehensive review exposes gaps in current knowledge of phase II enzyme and drug transporter…

CertaraJanuary 3, 2024

Publication

Total and Free Blood and Plasma Concentration Changes in Pregnancy for Medicines Highly Bound to Plasma Proteins: Application of Physiologically Based Pharmacokinetic Modelling to Understand the Impact on Efficacy

For drugs highly bound to plasma proteins, changes in concentrations of free drug may have…

CertaraJanuary 3, 2024

Higher Standards: Achieving Cleaner Data, Faster, from Protocol to Submission

Real-world application of PBPK in drug discovery

Industrializing Quantitative Systems Pharmacology (QSP): Why now and how.

Moving from Molecule to Market

MedCity News | How the IRA Has Created a New Environment for Biosimilars

Clinical Research News | Trendspotting: What’s Coming for Clinical Trials and Research in 2024

Bio-IT World | Trendspotting: What’s Coming for Biotech in 2024

Physiologically Based Pharmacokinetic modelling of drugs in pregnancy: A mini-review on availability and limitations

A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy

Total and Free Blood and Plasma Concentration Changes in Pregnancy for Medicines Highly Bound to Plasma Proteins: Application of Physiologically Based Pharmacokinetic Modelling to Understand the Impact on Efficacy

Newsletter sign up

Quick links

Solutions

Contact